DK1123387T3 - MN-gen og protein - Google Patents

MN-gen og protein

Info

Publication number
DK1123387T3
DK1123387T3 DK99955151T DK99955151T DK1123387T3 DK 1123387 T3 DK1123387 T3 DK 1123387T3 DK 99955151 T DK99955151 T DK 99955151T DK 99955151 T DK99955151 T DK 99955151T DK 1123387 T3 DK1123387 T3 DK 1123387T3
Authority
DK
Denmark
Prior art keywords
protein
proteins
polypeptides
disclosed
encode
Prior art date
Application number
DK99955151T
Other languages
English (en)
Inventor
Jan Zavada
Silvia Pastorekova
Jaromir Pastorek
Original Assignee
Inst Virology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/178,115 external-priority patent/US6297041B1/en
Priority claimed from US09/177,776 external-priority patent/US6297051B1/en
Application filed by Inst Virology filed Critical Inst Virology
Application granted granted Critical
Publication of DK1123387T3 publication Critical patent/DK1123387T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK99955151T 1998-10-23 1999-10-22 MN-gen og protein DK1123387T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/178,115 US6297041B1 (en) 1992-03-11 1998-10-23 MN gene and protein
US09/177,776 US6297051B1 (en) 1997-01-24 1998-10-23 MN gene and protein
PCT/US1999/024879 WO2000024913A2 (en) 1998-10-23 1999-10-22 Mn gene and protein

Publications (1)

Publication Number Publication Date
DK1123387T3 true DK1123387T3 (da) 2008-02-25

Family

ID=26873634

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99955151T DK1123387T3 (da) 1998-10-23 1999-10-22 MN-gen og protein

Country Status (11)

Country Link
EP (2) EP1123387B1 (da)
JP (3) JP3910798B2 (da)
AT (1) ATE376056T1 (da)
AU (1) AU758957C (da)
CA (1) CA2347649C (da)
CY (1) CY1107268T1 (da)
DE (1) DE69937364T2 (da)
DK (1) DK1123387T3 (da)
ES (1) ES2296412T3 (da)
NO (1) NO328884B1 (da)
WO (1) WO2000024913A2 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902890B1 (en) 1999-11-04 2005-06-07 Diadexus, Inc. Method of diagnosing monitoring, staging, imaging and treating cancer
US20040077081A1 (en) 2001-02-07 2004-04-22 Egbert Oosterwijk Hybridoma cell line g250 and its use for producing monoclonal antibodies
AR036833A1 (es) * 2001-10-18 2004-10-06 Bayer Corp Anticuerpos humanos que se unen a mn y tienen actividad neutralizante de la adhesion celular.
US7910549B2 (en) * 2001-12-13 2011-03-22 Institute Of Virology Of The Slovak Academy Of Sciences MN gene and protein
WO2003100029A2 (en) * 2002-02-21 2003-12-04 Bayer Healthcare Mn/ca ix-specific monoclonal antibodies generated from mn/ca ix-deficient mice and methods of use
DK1487972T3 (da) 2002-02-21 2015-10-19 Inst Virology MN/CA IX-specifikke, monoklonale antistoffer genereret fra MN/CA IX-fattige mus, samt anvendelsesfremgangsmåder
CA2704273C (en) 2002-02-21 2016-01-05 Institute Of Virology Mn/ca ix-antibody binding specifically to non-immunodominant epitope of mn/ca ix and uses thereof
US7632496B2 (en) 2002-07-01 2009-12-15 Wilex Ag Co-administration of cG250 and IL-2 or IFN-α for treating cancer such as renal cell carcinomas
WO2004017923A2 (en) * 2002-08-23 2004-03-04 Chiron Corporation Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix
WO2004048544A2 (en) 2002-11-26 2004-06-10 Bayer Healthcare Ca ix-specific inhibitors
EP1673630A4 (en) * 2003-10-16 2009-04-29 Inst Virology MN / AC IX AND PROGNOSIS OF CANCER
WO2005108623A2 (en) 2004-05-04 2005-11-17 Bayer Healthcare Mn/ca ix/ ca9 and renal cancer prognosis
US7820159B2 (en) 2006-10-31 2010-10-26 Instiute of Virology of the Slovak Academy of Sciences MN/CA IX and EGFR pathway inhibition
US8399624B1 (en) * 2009-06-25 2013-03-19 Esbatech, An Alcon Biomedical Research Unit Llc Acceptor framework for CDR grafting
WO2014128258A1 (en) 2013-02-22 2014-08-28 Wilex Ag Caix stratification based cancer treatment
CZ2014527A3 (cs) * 2014-08-05 2016-02-17 Ústav Organické Chemie A Biochemie Akademie Věd Čr, V.V.I. Způsob detekce aktivní formy analytů ve vzorku a stanovení schopnosti dalších látek vázat se do aktivních míst těchto analytů

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2861695A (en) * 1994-06-15 1996-01-05 Ciba Corning Diagnostics Corp. Mn gene and protein
US6329501B1 (en) * 1997-05-29 2001-12-11 Auburn University Methods and compositions for targeting compounds to muscle
AU3714499A (en) * 1998-05-14 1999-11-29 Pasteur Merieux Serums Et Vaccins Hepatitis c virus mimotopes

Also Published As

Publication number Publication date
JP4488373B2 (ja) 2010-06-23
JP2007145843A (ja) 2007-06-14
DE69937364D1 (de) 2007-11-29
NO20011926L (no) 2001-06-19
EP1123387A2 (en) 2001-08-16
JP2008069151A (ja) 2008-03-27
ATE376056T1 (de) 2007-11-15
EP1832653A1 (en) 2007-09-12
NO328884B1 (no) 2010-06-07
AU758957B2 (en) 2003-04-03
CY1107268T1 (el) 2012-11-21
CA2347649C (en) 2012-03-13
DE69937364T2 (de) 2008-07-17
JP3910798B2 (ja) 2007-04-25
EP1123387B1 (en) 2007-10-17
WO2000024913A2 (en) 2000-05-04
JP4044597B2 (ja) 2008-02-06
ES2296412T3 (es) 2008-04-16
CA2347649A1 (en) 2000-05-04
AU1132300A (en) 2000-05-15
WO2000024913A3 (en) 2000-09-14
NO20011926D0 (no) 2001-04-19
AU758957C (en) 2004-08-12
JP2002528085A (ja) 2002-09-03

Similar Documents

Publication Publication Date Title
CY1107268T1 (el) Μν γονιδιο και πρωτεϊνη
NO20100685L (no) Polypeptid samt anvendelse derav og peptidkompleks, og fremgangsmate for identifisering av et organisk eller uorganisk molekyl
NO990086D0 (no) Avkortete, oppl÷selige tumornekrosefaktorreseptorer av type I og type II
DE3785186D1 (de) Bindungsmolekuele mit einzelpolypeptidkette.
NO994870D0 (no) Humaniserte antistoffer og metoder for aa danne humaniserte antistoffer
IL123189A0 (en) Colon cell and colon cancer cell associated nucleic acid molecules protein and peptides
NO2007015I1 (no) Ranibizumab
DK1294876T3 (da) EV-VEGF-nukleinsyrer og -polypeptider samt fremgangsmåder til deres benyttelse
ATE541931T1 (de) Il-17-homologe polypeptide und ihre therapeutische verwendung
NO2004002I2 (no) Adalimumab
DK2314623T3 (da) Il-1 beta-bindende antistoffer og fragmenter deraf
DK1218504T3 (da) GL50 molekyler og anvendelser deraf
ATE541935T1 (de) Wachstumshormon fusionprotein
WO2002005843A3 (en) Human rrp sequences and methods of use
ATE446510T1 (de) Kontrolle des wachstums und der reparatur von gastrointestinalgewebe durch gastrokine
DE60313743D1 (de) Mit influenzavirus-hämagglutinin und influenza m2 pseudotypisierte retrovirusvektoren zur zuführung von genen
EP0603672A3 (de) Verfahren zur Herstellung von rekombinanten und synthetischen Peptiden und deren Verwendung.
DK1233980T3 (da) Nukleinsyremolekyle, omfattende en nukleinsyresekvens, der koder for et hæmocyanin, og mindst en intronsekvens
DK0456698T3 (da) Hidtil ukendte ekspressionsvektorer og fremgangsmåder til intracellulær proteinekspression
Wood The biochemical analysis of Escherichia coli helicase IV and the identification and cloning of the genetic locus.
DK1191101T3 (da) PRO241 polypeptider og nucleinsyre kodende herfor